Vertex Pharmaceuticals is picking up momentum in its strategy of branching out beyond cystic fibrosis.
About 20 patients have had their cells collected for Casgevy …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.